- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- South America Anesthesia Drugs Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Anaesthesia is a way to control pain during a surgery or procedure by using a medicine called anaesthetics. It can help control your breathing, blood pressure, blood flow, and heart rate and rhythm. Anaesthesia is used to Relax you, Block pain, Make you sleepy or forgetful, Make you unconscious for your surgery. Other medicines may be used along with anaesthesia, such as ones to help you relax or to reverse the effects of anaesthesia.
South America Anesthesia Drugs Market Segments Size & Growth:
South America Anesthesia drugs market size is projected to reach approximately $1450 million by the end of 2024 with a CAGR of close to 1.8% from $990 million in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Rising number of surgeries, New approvals of anaesthetic drugs, and Increase in some cosmetic surgeries. However, Side effects of general anaesthetics, Lack of skilled anesthesiologists and Regulatory issues are thereby hampering the market growth.
South America Anesthesia Drugs Market Segments Share:
South America Anesthesia drugs market is categorised into Type which comprises of Saddle Block Anesthesia, Peripheral Nerve Block, Local Anesthesia, IV Regional Anesthesia, Interscalene block, spinal Anesthesia, and General Anesthesia. Among them, General Anesthesia segment holds the most significant share in the market due to various growth factors. By Route of Administration, the market is segmented into Injection and Inhalation. Among them, Injection segment holds the most significant share. By Geography, Brazil is projected to dominate the market with the most significant share and the growth in the South America economies is mainly attributed because of huge profit margins and growth prospects.
South America Anesthesia Drugs Market Trends:
- Inhaled agents, such as isoflurane and perhaps the experimental agent, desflurane, will maintain or achieve their popularity because of the relative ease of administration and wide margins of safety. Propofol, the most recent intravenous anaesthetic available for clinical use, has already gained full acceptance because of its dual function as an induction and maintenance agent and its appropriateness for use in the ambulatory surgical population.
- The role of midazolam in anaesthesia practice has increased to such an extent that it has largely increased the use of diazepam (Valium). The introduction of the antagonist, flumazenil, will undoubtedly enhance the safety and efficacy of midazolam as well as broaden its applicability of use across various patient populations.
- The use of muscle relaxants as a critical component of anaesthetic management has led to the development of some new drugs in this classification. Pharmacologic management of patients under anaesthesia will at some future date likely include the administration of alpha two agonists. Administration of these drugs can reduce anaesthetic requirements of traditional agents by as much as 50%.
- New drugs will be incorporated into the practice of anaesthesia as that will promote rapid uptake, low toxicity, intense analgesia, easy reversibility, shorter durations, and fewer side effects. One measure of success relative to pharmacologic development in anaesthesia is the recent and dramatic decreases in patient morbidity and mortality figures over the last decade.
South America Anesthesia Drugs Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players, such as
- Pfizer
- Abbott
- Baxter
- AbbVie
- Braun
1.Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Decrease in the recovery time after surgery
4.1.2 Reduction in the cost of newly invented drugs
4.1.3 Development of new sedative seven anaesthetic drugs
4.1.4 Increasing number of surgeries
4.2 Restraints
4.2.1 Risk of adverse reactions to anaesthesia drugs
4.2.2 Lack of skilled anaesthetists to administer the drugs
4.2.3 Risk of side effects of anaesthesia drugs
4.3 Opportunities
4.3.1 Increase in M&A
4.3.2 Growing focus on developing anaesthetics for new ROA
4.4 Challenges
4.4.1 Lack skilled anesthesiologists
4.4.2 Drug shortages coupled with the fiscal cliff
4.4.3 Side effects coupled with product recalls
5. South America Anesthesia Drugs Market – By Type
5.1 General Anesthesia
5.2 Spinal Anesthesia
5.3 Interscalene block
5.4 IV Regional Anesthesia
5.5 Local Anesthesia
5.6 Peripheral Nerve Block
5.7 Saddle Block Anesthesia
6. South America Anesthesia Drugs Market-By Routes of Administration
6.1 Inhalation
6.2 Injection
7. South America Anesthesia Drugs Market – By Country
7.1.Introduction
7.2. Brazil
7.3. Argentina
7.4. Chile
7.5 Rest of South America
8. Company Profiles
8.1 Mylan N.V.
8.2 Hikma Pharmaceuticals PLC
8.3 Fresenius Kabi
8.4 B. Braun
8.5 Aspen
8.6 AbbVie
8.7 Baxter
8.8 Hospira
8.9 Abbott
8.10 Piramal
8.11 AstraZeneca
8.12 Roche
8.13 Novartis
8.14 Pfizer
8.15 Boehringer Ingelheim
9. South America Anesthesia Drugs Market – Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,988.22 - €6,627.39
- INR: ₹179,956.59 - ₹599,855.30
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,698.73 - £5,662.44
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Anaesthesia is a way to control pain during a surgery or procedure by using a medicine called anaesthetics. It can help control your breathing, blood pressure, blood flow, and heart rate and rhythm. Anaesthesia is used to Relax you, Block pain, Make you sleepy or forgetful, Make you unconscious for your surgery. Other medicines may be used along with anaesthesia, such as ones to help you relax or to reverse the effects of anaesthesia.
South America Anesthesia Drugs Market Segments Size & Growth:
South America Anesthesia drugs market size is projected to reach approximately $1450 million by the end of 2024 with a CAGR of close to 1.8% from $990 million in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Rising number of surgeries, New approvals of anaesthetic drugs, and Increase in some cosmetic surgeries. However, Side effects of general anaesthetics, Lack of skilled anesthesiologists and Regulatory issues are thereby hampering the market growth.
South America Anesthesia Drugs Market Segments Share:
South America Anesthesia drugs market is categorised into Type which comprises of Saddle Block Anesthesia, Peripheral Nerve Block, Local Anesthesia, IV Regional Anesthesia, Interscalene block, spinal Anesthesia, and General Anesthesia. Among them, General Anesthesia segment holds the most significant share in the market due to various growth factors. By Route of Administration, the market is segmented into Injection and Inhalation. Among them, Injection segment holds the most significant share. By Geography, Brazil is projected to dominate the market with the most significant share and the growth in the South America economies is mainly attributed because of huge profit margins and growth prospects.
South America Anesthesia Drugs Market Trends:
- Inhaled agents, such as isoflurane and perhaps the experimental agent, desflurane, will maintain or achieve their popularity because of the relative ease of administration and wide margins of safety. Propofol, the most recent intravenous anaesthetic available for clinical use, has already gained full acceptance because of its dual function as an induction and maintenance agent and its appropriateness for use in the ambulatory surgical population.
- The role of midazolam in anaesthesia practice has increased to such an extent that it has largely increased the use of diazepam (Valium). The introduction of the antagonist, flumazenil, will undoubtedly enhance the safety and efficacy of midazolam as well as broaden its applicability of use across various patient populations.
- The use of muscle relaxants as a critical component of anaesthetic management has led to the development of some new drugs in this classification. Pharmacologic management of patients under anaesthesia will at some future date likely include the administration of alpha two agonists. Administration of these drugs can reduce anaesthetic requirements of traditional agents by as much as 50%.
- New drugs will be incorporated into the practice of anaesthesia as that will promote rapid uptake, low toxicity, intense analgesia, easy reversibility, shorter durations, and fewer side effects. One measure of success relative to pharmacologic development in anaesthesia is the recent and dramatic decreases in patient morbidity and mortality figures over the last decade.
South America Anesthesia Drugs Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players, such as
- Pfizer
- Abbott
- Baxter
- AbbVie
- Braun
1.Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Decrease in the recovery time after surgery
4.1.2 Reduction in the cost of newly invented drugs
4.1.3 Development of new sedative seven anaesthetic drugs
4.1.4 Increasing number of surgeries
4.2 Restraints
4.2.1 Risk of adverse reactions to anaesthesia drugs
4.2.2 Lack of skilled anaesthetists to administer the drugs
4.2.3 Risk of side effects of anaesthesia drugs
4.3 Opportunities
4.3.1 Increase in M&A
4.3.2 Growing focus on developing anaesthetics for new ROA
4.4 Challenges
4.4.1 Lack skilled anesthesiologists
4.4.2 Drug shortages coupled with the fiscal cliff
4.4.3 Side effects coupled with product recalls
5. South America Anesthesia Drugs Market – By Type
5.1 General Anesthesia
5.2 Spinal Anesthesia
5.3 Interscalene block
5.4 IV Regional Anesthesia
5.5 Local Anesthesia
5.6 Peripheral Nerve Block
5.7 Saddle Block Anesthesia
6. South America Anesthesia Drugs Market-By Routes of Administration
6.1 Inhalation
6.2 Injection
7. South America Anesthesia Drugs Market – By Country
7.1.Introduction
7.2. Brazil
7.3. Argentina
7.4. Chile
7.5 Rest of South America
8. Company Profiles
8.1 Mylan N.V.
8.2 Hikma Pharmaceuticals PLC
8.3 Fresenius Kabi
8.4 B. Braun
8.5 Aspen
8.6 AbbVie
8.7 Baxter
8.8 Hospira
8.9 Abbott
8.10 Piramal
8.11 AstraZeneca
8.12 Roche
8.13 Novartis
8.14 Pfizer
8.15 Boehringer Ingelheim
9. South America Anesthesia Drugs Market – Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.